Log in

NYSE:WAT - Waters Stock Price, Forecast & News

$223.70
-1.25 (-0.56 %)
(As of 12/6/2019 06:33 AM ET)
Today's Range
$222.00
Now: $223.70
$225.78
50-Day Range
$209.49
MA: $217.17
$225.09
52-Week Range
$173.41
Now: $223.70
$255.21
Volume425,108 shs
Average Volume579,330 shs
Market Capitalization$14.41 billion
P/E Ratio26.98
Dividend YieldN/A
Beta1.04
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. Read More…

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
CUSIP94184810
Phone508-478-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.42 billion
Cash Flow$10.00 per share
Book Value$20.69 per share

Profitability

Net Income$593.79 million

Miscellaneous

Employees7,200
Market Cap$14.41 billion
Next Earnings Date1/22/2020 (Estimated)
OptionableOptionable

Receive WAT News and Ratings via Email

Sign-up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter.


Waters (NYSE:WAT) Frequently Asked Questions

What is Waters' stock symbol?

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

How will Waters' stock buyback program work?

Waters announced that its Board of Directors has initiated a share buyback program on Tuesday, April 24th 2018, which allows the company to repurchase $3,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy up to 18.2% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's board believes its stock is undervalued.

How were Waters' earnings last quarter?

Waters Co. (NYSE:WAT) issued its earnings results on Tuesday, October, 29th. The medical instruments supplier reported $2.13 earnings per share for the quarter, hitting the Zacks' consensus estimate of $2.13. The medical instruments supplier earned $577.28 million during the quarter, compared to the consensus estimate of $588.35 million. Waters had a return on equity of 77.73% and a net margin of 23.98%. The company's revenue was down .1% on a year-over-year basis. During the same period in the previous year, the company posted $1.92 earnings per share. View Waters' Earnings History.

When is Waters' next earnings date?

Waters is scheduled to release their next quarterly earnings announcement on Wednesday, January 22nd 2020. View Earnings Estimates for Waters.

What guidance has Waters issued on next quarter's earnings?

Waters updated its fourth quarter earnings guidance on Tuesday, October, 29th. The company provided EPS guidance of $2.95-3.05 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.23. The company issued revenue guidance of $715-729 million, compared to the consensus revenue estimate of $735.22 million.

What price target have analysts set for WAT?

11 analysts have issued twelve-month price targets for Waters' shares. Their forecasts range from $177.00 to $260.00. On average, they expect Waters' stock price to reach $207.73 in the next twelve months. This suggests that the stock has a possible downside of 7.1%. View Analyst Price Targets for Waters.

What is the consensus analysts' recommendation for Waters?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 6 sell ratings and 5 hold ratings for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Waters.

Has Waters been receiving favorable news coverage?

Media headlines about WAT stock have been trending very negative on Friday, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Waters earned a news sentiment score of -3.0 on InfoTrie's scale. They also gave press coverage about the medical instruments supplier a news buzz of 8.0 out of 10, meaning that recent news coverage is very likely to have an effect on the company's share price in the near term. View News Stories for Waters.

Who are some of Waters' key competitors?

What other stocks do shareholders of Waters own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), Home Depot (HD), Alibaba Group (BABA), Honeywell International (HON), CVS Health (CVS), Raytheon (RTN), Verizon Communications (VZ), Cisco Systems (CSCO), NVIDIA (NVDA) and QUALCOMM (QCOM).

Who are Waters' key executives?

Waters' management team includes the folowing people:
  • Christopher James O'Connell, Chairman & CEO (Age 52)
  • Mr. Christopher James O'Connell, Chairman & CEO (Age 52)
  • Ms. Sherry L. Buck, Sr. VP & CFO (Age 55)
  • Mr. Francis S. Kim, Sr. VP of Global Operations (Age 52)
  • Mr. Robert G. Carson, Sr. VP of Corp. Devel. & Interim Pres of TA Bus. (Age 45)

Who are Waters' major shareholders?

Waters' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Massachusetts Financial Services Co. MA (8.65%), State Street Corp (4.67%), Marathon Asset Management LLP (0.69%), Man Group plc (0.69%), Select Equity Group L.P. (0.67%) and Beck Mack & Oliver LLC (0.58%). Company insiders that own Waters stock include Christopher A Kuebler, David Terricciano, Edward Conard, Elizabeth B Rae, Eugene G Cassis, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View Institutional Ownership Trends for Waters.

Which institutional investors are selling Waters stock?

WAT stock was sold by a variety of institutional investors in the last quarter, including State of Tennessee Treasury Department, State Street Corp, First Trust Advisors LP, Robecosam AG, Fenimore Asset Management Inc., Pictet Asset Management Ltd., Marathon Asset Management LLP and Harvey Investment Co. LLC. Company insiders that have sold Waters company stock in the last year include Edward Conard, Elizabeth B Rae, Ian King, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View Insider Buying and Selling for Waters.

Which institutional investors are buying Waters stock?

WAT stock was acquired by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Select Equity Group L.P., Anchor Capital Advisors LLC, State of New Jersey Common Pension Fund D, Man Group plc, Assenagon Asset Management S.A., California Public Employees Retirement System and Ferguson Wellman Capital Management Inc.. View Insider Buying and Selling for Waters.

How do I buy shares of Waters?

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Waters' stock price today?

One share of WAT stock can currently be purchased for approximately $223.70.

How big of a company is Waters?

Waters has a market capitalization of $14.41 billion and generates $2.42 billion in revenue each year. The medical instruments supplier earns $593.79 million in net income (profit) each year or $8.29 on an earnings per share basis. Waters employs 7,200 workers across the globe.View Additional Information About Waters.

What is Waters' official website?

The official website for Waters is http://www.waters.com/.

How can I contact Waters?

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]


MarketBeat Community Rating for Waters (NYSE WAT)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  392 (Vote Outperform)
Underperform Votes:  532 (Vote Underperform)
Total Votes:  924
MarketBeat's community ratings are surveys of what our community members think about Waters and other stocks. Vote "Outperform" if you believe WAT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WAT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/6/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel